Bimuno® GOS reaches new 120-publication milestone

Clasado Biosciences (‘Clasado’) has revealed that its multi award-winning prebiotic ingredient, Bimuno® GOS, has now surpassed the landmark of 120 scientific publications backing its effectiveness in supporting health & wellbeing through microbiome modulation.

Available to formulators around the world both through Clasado and from a multinational network of distributors, Bimuno GOS is the most scientifically backed prebiotic galactooligosaccharide in the market. It is suitable for use in a wide range of nutraceutical and functional food and beverage products targeting areas such as gastrointestinal health, immune support and athletic health.

Notably, the latest study taking Bimuno GOS over its latest threshold is a new synbiotic study, conducted in collaboration with Probi® AB. The study explored the synbiotic potential of Bimuno GOS when combined with two well established probiotics, which demonstrated one of the first verified synergistic effects in a commercially available synbiotic concept. 

Dr Lucien Harthoorn, R&D Director at Clasado, commented: “As consumer interest in the gut microbiome has evolved and developed, so have we. Now, we celebrate another step forward in the scientific journey of Bimuno GOS. What was already the most studied ingredient of its kind is now in an even stronger proposition for health brands and their formulators. Over time, our highly accomplished R&D team has continued to develop the science around Bimuno GOS to highlight its efficacy, and we are thrilled that the number of published research papers has now surpassed 120, which includes more than 20 clinical trials.

“It’s particularly fitting that our synbiotic study in partnership with Probi, which offers formulators with a verified synergistic synbiotic for their product development, is the one to take us past this milestone. At Clasado, we are a business that is looking firm towards the future, and for our customers that also means anticipating health market trends and responding effectively. For many nutraceutical brands, that future includes synbiotics, so we’re delighted to be able to demonstrate the role Bimuno can play in this exciting and upcoming area of health management.”

Bimuno GOS selectively nourishes bacteria, such as Bifidobacteriaand Lactobacilli, ‘good’ bacteria in the gut microbiome that are associated with several important host health areas. The ingredient, backed by the extensive experience of the Clasado team, is an ideal choice for formulators looking to meet the needs of today’s health audience, where scientific backing is essential.

Click here to learn more about the science behind Bimuno GOS.